Page last updated: 2024-10-29

indomethacin and Anti-Phospholipid Antibody Syndrome

indomethacin has been researched along with Anti-Phospholipid Antibody Syndrome in 3 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Takkar, B1
Khokhar, S1
Kumar, U1
Venkatesh, P1
Opara, R1
Robbins, DL1
Ziboh, VA1
Marrakchi, H1
Fazaa, B1
Gorgi, Y1
Jellouli, A1
Mokhtar, I1
Kamoun, MR1

Reviews

1 review available for indomethacin and Anti-Phospholipid Antibody Syndrome

ArticleYear
[Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature].
    La Tunisie medicale, 1995, Volume: 73, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Antiphospholipid; Antiphospholipid Syndrome; Ar

1995

Other Studies

2 other studies available for indomethacin and Anti-Phospholipid Antibody Syndrome

ArticleYear
Necrotising scleritis, keratitis and uveitis in primary antiphospholipid syndrome.
    BMJ case reports, 2018, May-14, Volume: 2018

    Topics: Administration, Oral; Administration, Topical; Anti-Inflammatory Agents, Non-Steroidal; Antiphosphol

2018
Cyclic-AMP agonists inhibit antiphospholipid/beta2-glycoprotein I induced synthesis of human platelet thromboxane A2 in vitro.
    The Journal of rheumatology, 2003, Volume: 30, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Anticardiolipin; Antiphospholipid Syndrome; Ara

2003